BeStock  
股票 › 生物科技 › VRTX

福泰制药 VRTX

美股市值排名 #142生物科技基因编辑
$547.09 +$4.59 (+0.85%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $548.00 +0.17%
开盘$531.53
昨收$542.50
当日区间$531.53 – $548.76
成交量1.27M
市值$138.71B
市盈率(TTM)35.2
股息率–

基本面

最新报告季度:Q2, ended Jun 2026

营收$3.33B+12.5% YoY
营业利润$1.27B+9.9% YoY
净利润$1.10B+6.5% YoY
摊薄每股收益$4.31+8.0% YoY
自由现金流$1.01B+9.3% YoY
经营现金流$1.13B

营收,近8个季度

$2.8BSep '24$2.9BDec '24$2.8BMar '25$3.0BJun '25$3.1BSep '25$3.2BDec '25$3.0BMar '26$3.3BJun '26

净利润,近8个季度

$1.0BSep '24$913.0MDec '24$646.3MMar '25$1.0BJun '25$1.1BSep '25$1.2BDec '25$1.0BMar '26$1.1BJun '26

各季度摊薄每股收益

4.01Sep '243.50Dec '242.49Mar '253.99Jun '254.20Sep '254.65Dec '254.02Mar '264.31Jun '26

各季度自由现金流

$1.3BSep '24$492.0MDec '24$778.2MMar '25$927.4MJun '25$1.1BSep '25$348.6MDec '25$1.3BMar '26$1.0BJun '26

年度营收

$6.2BFY20$7.6BFY21$8.9BFY22$9.9BFY23$11.0BFY24$12.0BFY25

盈利能力与资产负债表

毛利率86.0%
营业利润率37.9%
净利率35.0%
净资产收益率23.5%
资产收益率17.1%
投入资本回报率19.5%
流动比率3.19
负债/资产比率26.2%
现金及投资$7.85B
总负债$1.98B
净现金(净负债)$5.87B
自由现金流/营收30.2%

营收构成

2026/Q2 季度

按业务线

  • TRIKAFTA/KAFTRIO$2.50B 74.9%
  • ALYFTREK$573.60M 17.2%
  • Other cystic fibrosis (CF) products$137.10M 4.1%
  • CASGEVY$76.40M 2.3%
  • JOURNAVX$49.60M 1.5%

利润表

项目 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
报告营业总收入 $3.33B $2.99B $12.00B $3.19B $3.08B
营业总收入 $3.33B $2.99B $12.00B $3.19B $3.08B
营业成本 $489.20M $392.80M $1.65B $466.00M $414.80M
毛利润 $2.84B $2.59B $10.35B $2.72B $2.66B
营业费用 $1.58B $1.46B $5.80B $1.59B $1.42B
销售及管理费用 $582.20M $493.70M $1.75B $487.00M $445.10M
研发费用 $993.80M $961.60M $4.04B $1.11B $977.70M
营业利润 $1.27B $1.14B $4.55B $1.13B $1.24B
非经营性利息净收入(支出) $120.60M $114.80M $477.60M $118.60M $122.40M
非经营性利息收入 $120.60M $114.80M $490.90M $121.90M $125.70M
其他收入(支出) $2.50M -$700,000.00 -$388.80M $82.10M -$62.40M
特殊收益(费用) -$21.80M -$700,000.00 -$381.10M $75.60M -$52.60M
-减:重组及并购费用 $400,000.00 $200,000.00 $2.10M $900,000.00 -$1.90M
-减:资本性资产减值 $0.00 $0.00 $379.00M $0.00 $0.00
-减:其他特殊支出 $21.40M $500,000.00 – – $54.50M
其他非经营性收入(支出) $24.30M – -$7.70M $6.50M -$9.80M
税前利润 $1.39B $1.25B $4.64B $1.33B $1.30B
税费 $292.00M $221.50M $690.00M $139.90M $215.90M
净利润 $1.10B $1.03B $3.95B $1.19B $1.08B
持续经营利润 $1.10B $1.03B $3.95B $1.19B $1.08B
归属母公司净利润 $1.10B $1.03B $3.95B $1.19B $1.08B
归属普通股股东净利润 $1.10B $1.03B $3.95B $1.19B $1.08B
基本每股收益 $4.34 $4.06 $15.46 $4.69 $4.24
摊薄每股收益 $4.31 $4.02 $15.32 $4.65 $4.20
非经营性利息支出 – – $13.30M $3.30M $3.30M

资产负债表

项目 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
总资产 $27.42B $26.48B $25.64B $25.64B $24.86B
流动资产合计 $12.54B $11.73B $11.20B $11.20B $10.57B
现金及现金等价物与短期投资 $7.85B $7.25B $6.61B $6.61B $6.29B
-现金及现金等价物 $6.14B $5.49B $5.08B $5.08B $4.94B
-短期投资 $1.71B $1.75B $1.52B $1.52B $1.35B
应收款 $2.13B $2.00B $2.05B $2.05B $1.95B
-应收账款 $2.13B $2.00B $2.05B $2.05B $1.95B
存货 $1.77B $1.77B $1.69B $1.69B $1.63B
其他流动资产 $791.90M $720.80M $110.90M $110.90M $709.40M
非流动资产合计 $14.88B $14.75B $14.44B $14.44B $14.29B
固定资产净值 $3.33B $3.29B $3.08B $3.08B $3.02B
-固定资产原值 $3.33B $3.29B $4.29B $4.29B $3.02B
投资及预付款 $5.79B $5.75B $5.71B $5.71B $5.72B
-可供出售证券 $5.79B $5.75B $5.71B $5.71B $5.72B
商誉及其他无形资产 $1.50B $1.51B $1.51B $1.51B $1.52B
-商誉 $1.09B $1.09B $1.09B $1.09B $1.09B
-其他无形资产 $412.80M $418.50M $424.20M $424.20M $429.80M
一年以上递延资产 $3.01B $2.95B $2.90B $2.90B $2.94B
其他非流动资产 $1.25B $1.26B $1.24B $1.24B $1.10B
负债合计 $7.18B $7.12B $6.98B $6.98B $7.54B
流动负债合计 $3.94B $3.88B $3.86B $3.86B $4.48B
应付款 $429.50M $489.30M $893.00M $893.00M $420.30M
-应付账款 $429.50M $489.30M $461.70M $461.70M $420.30M
一年内应计费用 $3.18B $2.98B $2.59B $2.59B $3.61B
其他流动负债 $329.40M $407.10M $127.70M $127.70M $441.50M
非流动负债合计 $3.24B $3.24B $3.12B $3.12B $3.07B
长期债务及融资租赁负债 $1.98B $1.99B $1.95B $1.95B $1.83B
-长期融资租赁负债 $1.98B $1.99B $1.95B $1.95B $1.83B
其他非流动负债 $1.26B $1.26B $267.40M $267.40M $1.23B
股东权益合计 $20.25B $19.36B $18.67B $18.67B $17.32B
股东权益 $20.25B $19.36B $18.67B $18.67B $17.32B
股本 $2.50M $2.50M $2.50M $2.50M $2.50M
-普通股 $2.50M $2.50M $2.50M $2.50M $2.50M
-优先股 $0.00 $0.00 $0.00 $0.00 $0.00
资本公积 $4.51B $4.74B $5.12B $5.12B $5.01B
留存收益 $15.69B $14.59B $13.56B $13.56B $12.37B
不影响留存收益的损益 $48.50M $24.80M -$15.90M -$15.90M -$64.50M
预付资产 – – $736.20M $736.20M –
-累计折旧 – – -$1.20B -$1.20B –
-应付税款合计 – – $103.10M $103.10M –
-其他应付款 – – $328.20M $328.20M –
短期债务及融资租赁负债 – – $77.30M $77.30M –
-一年内到期融资租赁负债 – – $77.30M $77.30M –
一年内递延负债 – – $171.80M $171.80M –
长期应付账款及其他应付款 – – $895.40M $895.40M –

现金流量表

项目 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
经营活动现金流 $1.13B $1.43B $3.63B $498.00M $1.24B
持续经营经营活动现金流净额 $1.13B $1.43B $3.63B $498.00M $1.24B
持续经营净利润 $1.10B $1.03B $3.95B $1.19B $1.08B
折旧、折耗与摊销 $56.50M $55.90M $209.80M $55.70M $54.00M
递延税款 -$69.70M -$65.30M -$510.80M $30.50M -$235.90M
其他非现金项目 -$16.40M -$5.00M $113.40M $23.10M -$16.30M
营运资金变动 -$115.00M $244.70M -$1.20B -$947.80M $149.60M
-应收款变动 -$140.20M $39.80M -$347.30M -$99.40M -$59.90M
-存货变动 -$27.70M -$97.70M -$524.20M -$77.40M -$131.10M
-预付资产变动 -$51.40M $173.40M -$396.00M -$250.60M -$40.90M
-应付账款及应计费用变动 $155.80M $106.10M -$80.10M -$626.20M $297.60M
-其他流动负债变动 -$51.50M $23.10M $148.50M $105.80M $83.90M
投资活动现金流净额 -$45.80M -$431.90M -$945.40M -$288.10M -$117.00M
持续经营投资活动现金流净额 -$45.80M -$431.90M -$945.40M -$288.10M -$117.00M
固定资产购置及出售净额 -$112.20M -$133.40M -$437.60M -$149.40M -$101.80M
投资购置及出售净额 $68.10M -$298.50M -$483.10M -$122.80M -$16.00M
筹资活动现金流 -$426.70M -$538.80M -$2.26B -$77.20M -$1.15B
持续经营筹资活动现金流净额 -$426.70M -$538.80M -$2.26B -$77.20M -$1.15B
普通股发行净额 -$473.80M -$565.40M -$2.39B -$130.90M -$1.16B
股票期权行使所得 $47.70M $27.00M $127.70M $54.00M $7.90M
其他筹资费用净额 -$600,000.00 -$400,000.00 $3.70M $1.10M $3.70M
期末现金余额 $6.15B $5.50B $5.09B $5.09B $4.95B
现金净变动 $652.90M $457.40M $424.70M $132.70M -$30.10M
期初现金余额 $5.50B $5.09B $4.57B $4.95B $4.98B
汇率变动影响 -$3.70M -$40.30M $90.90M $7.30M -$4.10M
自由现金流 $1.01B $1.29B $3.19B $348.60M $1.14B
无形资产购置及出售净额 – – $0.00 $0.00 $0.00
其他投资变动净额 – – -$24.70M -$15.90M $800,000.00
债务发行及偿还净额 – – -$5.40M -$1.40M -$1.40M
持续经营损益 – – – – $2.60M

讨论区

暂无评论——快来第一个聊聊 VRTX。

登录后参与讨论。

Scroll to Top